Bicycle Therapeutics Enters Neuroscience Arena through Collaboration with Dementia Discovery Fund Read more
Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A Funding Led by GV Read more
EC Approves LORVIQUA (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer Read more
Sensei Biotherapeutics Announces Clinical Trial Collaboration Agreement with AstraZeneca for Two Phase 2 Studies of SNS-301 Read more
Xencor Doses First Patient in Phase 1 Study of XmAb23104 for the Treatment of Patients with Advanced Solid Tumors Read more
FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis Read more
Skyhawk Therapeutics Announces Agreement with Takeda to Develop Novel Small Molecule RNA Splicing Modifiers for Neurodegenerative Diseases Read more